Coronary artery bypass graft surgery using the radial artery as a secondary conduit improves patient survival

John Lin1, Wen Cheng, Lawrence S Czer

  • 1Division of Cardiothoracic Surgery, Cedars Sinai Heart Institute, Los Angeles, CA.

Insights

The radial artery (RA) offers superior long-term survival compared to saphenous vein grafts in coronary artery bypass graft surgery (CABG). This survival benefit is particularly notable in diabetic patients, women, and the elderly, emerging after five years.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Grafting
  • Clinical Outcomes Research

Background:

  • The left internal thoracic artery is a standard for coronary artery bypass graft surgery (CABG).
  • Long-term outcomes of using the radial artery (RA) versus saphenous vein grafts as secondary conduits in CABG are not well-established.
  • Limited data exist comparing RA and saphenous vein grafts for long-term efficacy in CABG.

Purpose of the Study:

  • To compare the 12-year survival outcomes of radial artery (RA) versus saphenous vein grafts as secondary conduits in coronary artery bypass graft surgery (CABG).
  • To evaluate the long-term efficacy of RA grafts in specific patient subgroups, including diabetics, women, and the elderly.

Main Methods:

  • A propensity-matched analysis of 260 pairs of first-time isolated CABG patients (1996-2001) was conducted.
  • Multivariable logistic regression identified 18 baseline characteristics to define propensity for RA graft use.
  • Kaplan-Meier method estimated cumulative 12-year survival, comparing RA and saphenous vein grafts.

Main Results:

  • Radial artery (RA) grafts were associated with higher 12-year cumulative survival (hazard ratio 0.76; P=0.03) compared to saphenous vein grafts.
  • A significant survival advantage for RA grafts was observed in diabetic patients (P=0.005), women (P=0.02), and the elderly (P=0.04).
  • The protective effect of RA grafts became apparent approximately five years post-surgery.

Conclusions:

  • The radial artery (RA) serves as a superior secondary conduit in coronary artery bypass graft surgery (CABG), enhancing long-term patient survival.
  • This survival benefit is particularly pronounced in diabetic patients, women, and the elderly, manifesting more than five years after the procedure.
Abstract